Peter Kolovos is a partner in the firm's Securities Department, and a member of the Securities Litigation and Enforcement Practice Group. He joined the firm in 1997. He is also a member of the firm's Hiring Committee for the Boston office and of the Committee on Diversity.
Practice
Mr. Kolovos concentrates his practice on securities litigation and enforcement matters, as well as corporate and complex commercial litigation. He has represented numerous public companies and their officers and directors in federal and state securities litigation and enforcement matters, including securities fraud class actions, derivative litigation, and SEC, DOJ, and other federal and state regulatory investigations. He also has conducted internal investigations for companies in a variety of industries on issues such as revenue recognition, options backdating, and earnings management. His practice also has included a wide range of other complex litigation matters, including mergers and acquisitions disputes, closely-held corporation disputes, intellectual property litigation and commercial real estate disputes.
Recent Highlights
- Successful defense through trial, appeal, and certiorari to the United States Supreme Court of an investment company in a fiduciary duty and conspiracy action involving a closely-held corporation
- Obtained denial of class certification in a federal securities fraud class action for a life sciences company based upon a showing of inadequacy of lead counsel and atypicality of lead plaintiffs
- Successful defense of a medical device company and its officers in a securities fraud class action involving allegations of channel stuffing and improper revenue recognition
- Successful representation of a healthcare services provider and its officers and directors in a class action alleging breaches of fiduciary duties in connection with a merger transaction
- Successful representation of a pharmaceutical company in a federal securities fraud class action arising from the company's statements about a drug candidate's prospects for FDA approval
- Successful defense of a telecommunications company and its officers in obtaining dismissal of two securities fraud class actions
- Successful representation of a real estate investment and management company and its officers and directors in a class action alleging breaches of fiduciary duties in connection with a "going private" merger
- Representation of companies in a variety of industries, including manufacturing, technology, defense, insurance, software, and healthcare, in class actions, derivative suits, federal and state regulatory investigations and internal investigations
Honors and Awards
- Named a "Massachusetts Super Lawyers Rising Star" in securities litigation in the May 2005, 2006, 2007 and 2011 issues of Boston Magazine
Publications
- "Navigating The Minefield In The Economic Downturn: Financial And Legal Lessons From The Trenches: Interview with Peter Kolovos and Carol Palmer Winig." The Metropolitan Corporate Counsel, (January 2009).
- "Antitrust Law and Nonprofit Organizations: The Law School Accreditation Case," 71 N.Y.U. L. Rev. 689 (1996).
